Published in Pharma Investments, Ventures and Law Weekly, December 31st, 2006
This trend article about University of Chicago, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Data detailed in "Diverse effects of vascular endothelial growth factor on human pulmonary endothelial barrier and migration" have been presented. "Increased endothelial permeability is involved in the pathogenesis of many cardiovascular and pulmonary diseases. Vascular endothelial growth factor (VEGF) is a permeability-increasing cytokine," scientists in the United States report.
"At the same time, VEGF is known to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.